Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Recalls Leukocyte Reduction Device

A faulty filter on Haemonetics’ Leukotrap RC System prompts FDA recall.

Affected blood samples could have higher than expected leukocyte counts. Photo: www.raps.org
Affected blood samples could have higher than expected leukocyte counts. Photo: www.raps.org

A June 23rd article from Regulatory Affairs Professionals Society highlighted the recall of defective filters on a leukocyte reduction device that could yield higher than expected leukocyte counts in blood transfusions. Haemonetics issued a voluntary recall notice on June 8th, citing three specific defective lots, but later expanded the recall to include all lots of the device distributed between April 14th and June 27th.

On June 21st, Haemonetics sent a letter to customers instructing them to mark any blood samples extracted with the affected devices as "non-leukoreduced," unless they have been tested otherwise. The FDA’s Center for Biologics Research and Evaluation (CBER) released a safety advisory stating the tests can be conducted within 48 hours of filtration.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging